Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GLE1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
mRNA | NCOA3 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.007 |
mRNA | SCYL1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
mRNA | ASB12 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
mRNA | OR10G7 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
mRNA | PSMB8 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.007 |
mRNA | ELANE | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |
mRNA | AAMP | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
mRNA | GAPT | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
mRNA | ILDR2 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |